Interclean Shanghai

In the fight against the Corona virus, Bactiguard donates infection prevention to China

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

In the fight against the Corona virus, Bactiguard donates products for infection prevention to Chinese hospitals, at a market value of over 2 million SEK.

“To help fight the new corona virus (covid-19) and protect the most severely ill patients, we will donate products from Bactiguard’s and Vigilenz’s combined product portfolios to China”, says Stefan Grass, Chief Medical Officer and Deputy CEO.  

“Hydrocyn aqua is a water-based product that kills bacteria, fungi and virus within seconds without damaging or irritating the body. In the past, it has proven to have a powerful effect on earlier versions of the Corona virus and can thus be very useful for prevention of both the general public and healthcare professionals. Further, our catheters for infection prevention protect patients against the bacterial infections that often come as a complication of viral infections,” continues Stefan Grass.

HYDROCYN aqua® is a pH-neutral and water-based product that, unlike alcohol and chlorhexidine, isn’t toxic or harmful to the body. The active substance is hypochlorous acid (HOCl) which kills bacteria, fungi and virus within seconds. HYDROCYN aqua® is included in Bactiguard’s portfolio of products following the acquisition of Vigilenz and it is documented that the product kills 99.9% of previous variants of Coronavirus within 15-30 seconds.

HYDROCYN aqua® is CE marked (EU approved) and FDA approved in the US.

Bactiguard develops and provides infection prevention solutions which reduce the risk of healthcare associated infections. In viral infections, the body’s immune system is under stress, which increases the risk of secondary bacterial infections. Bactiguard’s unique coating prevents bacteria and other microbes from adhering to the surface of, for example, catheters, which reduces the risk of biofilm formation that lead to infections.

Recently, Bactiguard completed the acquisition of Malaysian Vigilenz, a manufacturer and supplier of medical devices and consumables, primarily within wound care and infection prevention, where HYDROCYN aqua® is an important part of the product portfolio.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »